FOLLOW US ON
The ECEF Hotline -
(732) 446-8520
About Us
About ECEF
President’s Message
ECEF Structure
Board of Directors
Medical Advisory Committees
Medical Advisory Committees
Research Project Submission and Review Sub Committee
Publication Review Sub Committee
Patient and Caregiver Support Group Sub Committee
International Sub Committee
Financial Statements
Resources
About This Disease
Esophagectomy Post Surgery Guide
Nutritional Guide Post Surgery
Articles
Services
Support Groups
Hours Hotline
Esophagectomy Post Surgical Guide
Get Involved
Donate Today
Research Projects
Events
Blog
DONATE »
JOIN »
Domvanalimab and zimberelimab in advanced gastric, gastroesophageal junction or esophageal cancer: a phase 2 trial
Categories
About this Disease
October 20, 2025
by Fightec.org
https://www.nature.com/articles/s41591-025-04022-w